IL239623A0 - Methods and compositions for admisitration of oxybutynin - Google Patents

Methods and compositions for admisitration of oxybutynin

Info

Publication number: IL239623A0
Authority: IL; Israel
Prior art keywords: admisitration; oxybutynin; compositions; methods
Prior art date: 2012-12-27

Application number

IL239623A

Other languages

Hebrew (he)

Original Assignee

Microdose Therapeutx Inc

Cook Robert

Byron David A

Fleming Scott

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-27

Filing date

2015-06-24

Publication date

2015-08-31

2012-12-27 Priority claimed from US13/728,706 external-priority patent/US9119777B2/en

2015-06-24 Application filed by Microdose Therapeutx Inc, Cook Robert, Byron David A, Fleming Scott filed Critical Microdose Therapeutx Inc

2015-08-31 Publication of IL239623A0 publication Critical patent/IL239623A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL239623A 2012-12-27 2015-06-24 Methods and compositions for admisitration of oxybutynin IL239623A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13/728,706 US9119777B2 (en)	2008-05-30	2012-12-27	Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en)	2012-12-27	2013-12-12	Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number	Publication Date
IL239623A0 true IL239623A0 (en)	2015-08-31

Family

ID=51021931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL239623A IL239623A0 (en)	2012-12-27	2015-06-24	Methods and compositions for admisitration of oxybutynin

Country Status (15)

Country	Link
EP (1)	EP2938329A4 (en)
JP (1)	JP2016504358A (en)
KR (1)	KR20150100902A (en)
CN (1)	CN104955444A (en)
AR (1)	AR094287A1 (en)
AU (1)	AU2013368298B2 (en)
BR (1)	BR112015015421A2 (en)
CA (1)	CA2895955A1 (en)
EA (1)	EA201591218A1 (en)
HK (2)	HK1216843A1 (en)
IL (1)	IL239623A0 (en)
MX (1)	MX2015008333A (en)
NZ (1)	NZ628479A (en)
UY (1)	UY35230A (en)
WO (1)	WO2014105446A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108495654B (en) *	2016-02-25	2022-10-25	久光制药株式会社	External liquid preparation
CR20220617A (en) *	2020-05-05	2023-02-09	Apnimed Inc	Polymorphic forms of (r)-oxybutynin hydrochloride

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1191930A2 (en) *	1999-05-20	2002-04-03	Sepracor Inc.	Methods for treatment of asthma using s-oxybutynin
US6339107B1 (en) *	2000-08-02	2002-01-15	Syntex (U.S.A.) Llc	Methods for treatment of Emphysema using 13-cis retinoic acid
EP1558563A1 (en) *	2002-10-29	2005-08-03	Pharmacia & Upjohn Company LLC	Quaternary ammonium compounds
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
WO2006047427A1 (en) *	2004-10-25	2006-05-04	Schering Corporation	M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) *	2008-05-30	2013-04-09	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin
EP3311820A1 (en) *	2008-02-26	2018-04-25	Sunovion Respiratory Development Inc.	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
EP2442657A4 (en) *	2009-06-16	2012-11-07	Wen Tan	Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) *	2009-10-21	2009-12-09	Innovata Ltd	Composition
WO2011120779A1 (en) *	2010-04-01	2011-10-06	Chiesi Farmaceutici S.P.A.	Process for preparing carrier particles for dry powders for inhalation
CA2812952A1 (en) *	2010-09-27	2012-04-12	Microdose Therapeutx, Inc.	Methods and compositions for disease treatment using inhalation

2013
- 2013-12-12 MX MX2015008333A patent/MX2015008333A/en unknown
- 2013-12-12 AU AU2013368298A patent/AU2013368298B2/en not_active Ceased
- 2013-12-12 KR KR1020157020335A patent/KR20150100902A/en not_active Ceased
- 2013-12-12 EP EP13867956.8A patent/EP2938329A4/en not_active Withdrawn
- 2013-12-12 CA CA2895955A patent/CA2895955A1/en not_active Abandoned
- 2013-12-12 EA EA201591218A patent/EA201591218A1/en unknown
- 2013-12-12 BR BR112015015421A patent/BR112015015421A2/en not_active IP Right Cessation
- 2013-12-12 HK HK16104715.8A patent/HK1216843A1/en unknown
- 2013-12-12 HK HK16103431.3A patent/HK1215396A1/en unknown
- 2013-12-12 NZ NZ628479A patent/NZ628479A/en not_active IP Right Cessation
- 2013-12-12 CN CN201380068230.5A patent/CN104955444A/en active Pending
- 2013-12-12 WO PCT/US2013/074759 patent/WO2014105446A1/en active Application Filing
- 2013-12-12 JP JP2015550444A patent/JP2016504358A/en active Pending
- 2013-12-20 UY UY0001035230A patent/UY35230A/en not_active Application Discontinuation
- 2013-12-27 AR ARP130105037A patent/AR094287A1/en unknown
2015
- 2015-06-24 IL IL239623A patent/IL239623A0/en unknown

Also Published As

Publication number	Publication date
HK1216843A1 (en)	2016-12-09
AU2013368298B2 (en)	2016-08-11
EP2938329A4 (en)	2016-08-10
UY35230A (en)	2015-01-30
NZ628479A (en)	2016-06-24
MX2015008333A (en)	2015-11-09
EA201591218A1 (en)	2015-11-30
AU2013368298A1 (en)	2015-07-02
BR112015015421A2 (en)	2017-07-11
AR094287A1 (en)	2015-07-22
WO2014105446A1 (en)	2014-07-03
JP2016504358A (en)	2016-02-12
CA2895955A1 (en)	2014-07-03
KR20150100902A (en)	2015-09-02
EP2938329A1 (en)	2015-11-04
CN104955444A (en)	2015-09-30
HK1215396A1 (en)	2016-08-26

Publication	Publication Date	Title
AP3965A (en)	2016-12-24	Anthelminitic compounds and compositions and method of using thereof
ZA201502880B (en)	2020-11-25	Compositions and methods for immunotherapy
EP2675471A4 (en)	2015-01-28	Hsa-related compositions and methods of use
EP2834322A4 (en)	2016-02-17	Biochar compositions and methods of use thereof
ZA201508059B (en)	2016-12-21	Compositions and methods of use of phorbol esters
IL234108A0 (en)	2014-09-30	Factor viii compositions and methods of making and using same
IL238943A0 (en)	2015-07-30	Controlled release compositions and methods of using
ZA201408594B (en)	2015-12-23	Xylitol-based anti-mucosal compositions and related methods and compositions
GB201200458D0 (en)	2012-02-22	Methods of preparing cells and compositions
IL227924A0 (en)	2013-09-30	Compositions and methods of use for determination of he4a
EP2852403A4 (en)	2016-04-20	Methods for modification of tissues
GB201315350D0 (en)	2013-10-09	Methods and compositions
GB201315347D0 (en)	2013-10-09	Methods and compositions
EP2867199A4 (en)	2015-12-02	Stable compositions of fesoterodine
IL239623A0 (en)	2015-08-31	Methods and compositions for admisitration of oxybutynin
AU2012901658A0 (en)	2012-05-10	Compositions and methods of use